BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11398061)

  • 1. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
    Rizzato G
    Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Fishbane S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine to prevent contrast nephropathy.
    Meine TJ; Washam JB
    Am Heart J; 2004 Mar; 147(3):440-1. PubMed ID: 14999191
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
    Safirstein R; Andrade L; Vieira JM
    N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].
    El Mahmoud R; Le Feuvre C; Le Quan Sang KH; Helft G; Beygui F; Batisse JP; Metzger JP
    Arch Mal Coeur Vaiss; 2003 Dec; 96(12):1157-61. PubMed ID: 15248440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
    MacNeill BD; Harding SA; Bazari H; Patton KK; Colon-Hernadez P; DeJoseph D; Jang IK
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):458-61. PubMed ID: 14624421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
    Mehran R; Brar S; Dangas G
    J Am Coll Cardiol; 2010 May; 55(20):2210-1. PubMed ID: 20466201
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-induced nephropathy: a review.
    Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
    Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality prevention of contrast-induced acute kidney injury.
    McCullough PA
    Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine for contrast nephropathy: more clinical science is required.
    Eddleston M; Goddard J; Bateman N
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
    Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we prevent acute kidney injury?
    Venkataraman R
    Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Faddy SC
    Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
    [No Abstract]   [Full Text] [Related]  

  • 15. From chaotic to coordinated clinical research: the case of acetylcysteine.
    Biondi-Zoccai GG; Abbate A; Valgimigli M; Testa L; Agostoni P
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668; author reply 1669. PubMed ID: 16908805
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
    Billinger M; Hess OM; Meier B
    Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephropathy caused by radiocontrast media].
    Kolarz M; Sułowicz W
    Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from contrast-induced nephropathy: is the answer in?
    Dean LS
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine as a preventive measure for acute renal failure: a plea for more accurate detection of renal function in critically ill patients.
    Schultz MJ
    Crit Care Med; 2007 Jun; 35(6):1633-4. PubMed ID: 17522549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.